SCHEMBL703655

SCHEMBL703655

Br[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
TSHR P16473 3/20 0.33
DPP4 P27487 2/20 0.33
MAPK1 P28482 2/20 0.33
BBOX1 O75936 1/20 0.33
EHMT2 Q96KQ7 1/20 0.33
EHMT1 Q9H9B1 1/20 0.33
TRPA1 O75762 1/20 0.33
F2 P00734 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
MAPT P10636 3/20 0.32
LMNA P02545 2/20 0.32
HTT P42858 1/20 0.32
NOTUM Q6P988 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL714180 0.97 ESR1 (0.40) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL191913 0.79 ALDH1A1 (0.39) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL191172 0.79 ALDH1A1 (0.39) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL21357918 0.76 ALDH1A1 (0.37) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL706716 0.76 ESR1 (0.40) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL28166503 0.76 ALDH1A1 (0.37) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL6931675 0.76 ALDH1A1 (0.36) ALDH1A1TDP1MAPK1
SCHEMBL18108096 0.73 TSHR (0.35) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL18108083 0.73 ALDH1A1 (0.35) ALDH1A1TDP1ESR1ESR2TSHR
SCHEMBL190639 0.73 ESR1 (0.44) ALDH1A1TDP1ESR1ESR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238771-A1 SUPPORTED RARE EARTH CATALYSTS AND CATALYTIC CH BORYLATION OF HYDROCARBONS IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2024-07-18 US claimed
EP-1420475-B1 Non-aqueous electrolyte and lithium battery using the same SAMSUNG SDI CO LTD (KR) 2016-02-03 EP claimed
EP-1435362-B1 Process for polymer hydrogenation using lithium hydride prepared from reactor equipped with high-speed injection nozzle KOREA KUMHO PETROCHEM CO LTD (KR) 2010-03-03 EP claimed
US-7244531-B2 Non-aqueous electrolyte and lithium battery using the same SAMSUNG SDI CO., LTD. (KR) 2007-07-17 US claimed
CN-1241283-C Non-aqueous electrolyte and lithium battery using the same SAMSUNG SDI CO LTD (KR) 2006-02-08 CN claimed
US-6951906-B1 Process for hydrogenating a conjugated diene polymer KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2005-10-04 US claimed
US-6864326-B2 Process for polymer hydrogenation using lithium hydride prepared from reactor equipped with high-speed injection nozzle KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2005-03-08 US claimed
EP-1124863-B1 PROCESS FOR HYDROGENATING A CONJUGATED DIENE POLYMER KOREA KUMHO PETROCHEM CO LTD (KR) 2004-07-21 EP claimed
US-20040132916-A1 Process for polymer hydrogenation using lithium hydride prepared from reactor equipped with high-speed injection nozzle KOREA KUMHO PETROCHEMICAL CO., LTD. 2004-07-08 US claimed
EP-1435362-A1 Process for polymer hydrogenation using lithium hydride prepared from reactor equipped with high-speed injection nozzle Korea Kumho Petrochemical Co. Ltd. (KR) 2004-07-07 EP claimed
CN-1501539-A Non-aqueous electrolyte and lithium battery using the same ����SDI��ʽ���� 2004-06-02 CN claimed
US-20040096737-A1 Non-aqueous electrolyte and lithium battery using the same SAMSUNG SDI CO., LTD. (KR) 2004-05-20 US claimed
EP-1420475-A2 Non-aqueous electrolyte and lithium battery using the same Samsung SDI Co. Ltd. (KR) 2004-05-19 EP claimed
EP-1124863-A1 PROCESS FOR HYDROGENATING A CONJUGATED DIENE POLYMER Korea Kumho Petrochemical Co. Ltd. (KR) 2001-08-22 EP claimed
WO-2000008069-A1 PROCESS FOR HYDROGENATING A CONJUGATED DIENE POLYMER KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2000-02-17 WO claimed
EP-0251732-B1 PROCESS FOR THE PREPARATION OF 2-HALOGENATED ERGOLINE DERIVATIVES RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1993-04-28 EP claimed
US-4816587-A Process for the preparation of 2-halogenated ergoline derivatives RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 1989-03-28 US claimed
EP-0251732-A2 Process for the preparation of 2-halogenated ergoline derivatives RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1988-01-07 EP claimed
EP-4737444-A1 PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS Gilead Sciences, Inc. (US) 2026-05-06 EP disclosed
US-4105648-A CROSSLINKED POLYACRYLAMIDES CONTAINING SILYL GROUPS CIBA-GEIGY CORPORATION (US) 1978-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238771-A1 SUPPORTED RARE EARTH CATALYSTS AND CATALYTIC CH BORYLATION OF HYDROCARBONS HAO2, SCO2, SOD1 ALDH1A1 2963/4885TDP1 3741/4885ESR1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.